Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
Tianjin Medical University Cancer Institute and Hospital
University of Pittsburgh
Children's Oncology Group
University of Kentucky
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Latin American Cooperative Oncology Group
National Institutes of Health Clinical Center (CC)
The University of Hong Kong
Fundación GECP
Actuate Therapeutics Inc.
Beijing Sanbo Brain Hospital
Hoosier Cancer Research Network
Albert Einstein College of Medicine
Novartis
OHSU Knight Cancer Institute
Sun Yat-sen University
Children's Hospital Los Angeles
Children's Oncology Group
Sun Yat-sen University
OHSU Knight Cancer Institute
Sun Yat-sen University
University of Colorado, Denver
Children's Oncology Group
Samsung Medical Center
Central Hospital, Nancy, France
Children's Oncology Group
City of Hope Medical Center
Dana-Farber Cancer Institute
Samsung Medical Center
National Institutes of Health Clinical Center (CC)
NYU Langone Health
NYU Langone Health
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seoul National University Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
NYU Langone Health